Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. Read more.
Call for papers: Multi-omics and Biomarkers
Biomarker Research is calling for submissions to our Collection on 'Multi-omics and Biomarkers.' This collection aims to explore innovative methodologies and applications in integrating multi-omics data to identify and validate biomarkers. Submissions should provide novel insights or comprehensive reviews that advance the field. Click to visit the Collection webpage.
Call for papers: Oncobiome
The new cross journal collection 'Oncobiome' is now open for submissions. The oncobiome encompasses the diverse microbial communities residing in and on the human body, which influence cancer development, progression, and treatment responses. By examining these interactions, our aim is to unravel the complex mechanisms through which the microbiome impacts oncogenesis and therapeutic outcomes. Click to visit the collection webpage.
CAHON: Stop hate crimes and racism
The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond.
Articles
-
-
Emerging strategies and novel therapeutic targets in acute myeloid leukemia: current advances and future directions
-
Development and validation of predictive models combining cell-Free DNA motifs and protein biomarkers for early detection of esophageal squamous cell carcinoma and precancerous lesion
-
Neurotransmitters in tumors: chemical cross-talk shaping tumor progression
-
Comprehensive assessment of homologous recombination deficiency via simultaneous methylation and mutation analysis in epithelial ovarian cancer: implications for PARP inhibitors efficacy
-
1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea
-
Roles of IFN-γ in tumor progression and regression: a review
-
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases
-
The landscape of bispecific T cell engager in cancer treatment
-
The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer
Aims and scope
Colorectal Cancer Awareness Month
In recognition of Colorectal Cancer Awareness Month this March, we have selected a collection of articles on colorectal cancer from across our open access portfolio. Together, these articles contribute to the evolving landscape of colorectal cancer research and the fight against this prevalent and impactful disease.
Announcing the launch of In Review
Biomarker Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Follow
Annual Journal Metrics
-
Citation Impact
Journal Impact Factor: 11.5 (2024)
5-year Journal Impact Factor: 11.8 (2024)
Source Normalized Impact per Paper (SNIP): 1.913 (2024)
SCImago Journal Rank (SJR): 3.296 (2024)
Speed
Submission to first editorial decision (median days): 7
Submission to acceptance (median days): 71
Usage 2024
Downloads: 1,131,858
Altmetric mentions: 279